Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BRKR
KYMR
Add up to 3 more stocks
BRKR
Bruker Corporation
-4.89%
$60.73-3.13Delayed quote: Oct 6, 2026, 1:45 PM EDT
Market Cap
$9.25B
52W Range
$32.37 - $66.98
KYMR
Kymera Therapeutics, Inc.
-5.04%
$104.31-5.54Delayed quote: Oct 6, 2026, 1:45 PM EDT
Market Cap
$8.58B
52W Range
$55.26 - $130.05
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | 28.62 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.85 | 5.69 |
| P/S Ratio | 2.64 | 81.72 |
| P/FCF Ratio | 98.46 | N/A |
| EV/EBITDA | 30.78 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 46.7% | 102.0% |
| Operating Margin | 3.6% | -891.3% |
| Net Margin | -2.0% | -285.4% |
| ROE | -3.0% | -19.9% |
| ROA | -1.2% | -18.2% |
| ROIC | 2.6% | -22.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.85 | 9.83 |
| Quick Ratio | 0.92 | N/A |
| Debt/Equity | 0.80 | 0.05 |
| Interest Coverage | 3.91 | -1403.21 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 0.2% | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.